MS
VERA icon

Maven Securities’s Vera Therapeutics VERA Stock Holding History

Maven Securities’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-64,240
Closed -$1.51M – 1128
2022
Q1 		$1.51M Buy
+64,240
New +$1.38M 0.05% 247
2021
Q3 		– Sell
-13,000
Closed -$178K – 1281
2021
Q2 		$178K Buy
+13,000
New +$202K 0.01% 951

Other funds holding VERA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Maven Securities's VERA Position: Q2 2022 in Review

Maven Securities sold out of Vera Therapeutics (VERA) in Q2 2022, closing a stake of 64,240 shares — an estimated $1.51M sold.

Maven Securities first reported a position in VERA in Q2 2021 and held it in 2 quarters. The position peaked at $1.51M in Q1 2022. 51 funds tracked by Wall St. Rank hold VERA as of Q2 2022.

  • Maven Securities reported no remaining Vera Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Maven Securities sold 64,240 Vera Therapeutics shares in Q2 2022, an estimated $1.51M.
  • Maven Securities first reported a position in Vera Therapeutics in Q2 2021 and held it in 2 quarters.
  • Maven Securities's Vera Therapeutics position peaked at $1.51M in Q1 2022.
  • 51 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2022.

Based on Maven Securities's 13F filing for Q2 2022, filed 15 Aug 2022.